{"id":"W4390754195","doi":"10.1016/j.ejca.2024.113530","title":"Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients","year":2024,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Pembrolizumab; Discontinuation; Medicine; Adverse effect; Internal medicine; Clinical trial; Immune system; Cancer; Oncology; Immunotherapy; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001830827,0.0003945645,0.0009856875,0.0003869302,0.0002601475,0.0006019294,0.00018672,0.0002547688,0.001119478],"category_scores_gemma":[0.001399425,0.000124646,0.0009725838,0.0006016607,0.0002030933,0.0003793951,0.0002426654,0.0006113048,0.000399192],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005143868,"about_ca_system_score_gemma":0.0005256151,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003760755,"about_ca_topic_score_gemma":0.0004556483,"domain_scores_codex":[0.9991485,0.0002287701,0.0001023701,0.0001739436,0.0002495298,0.00009690119],"domain_scores_gemma":[0.998894,0.0002544254,0.0003798748,0.000132935,0.0002422235,0.00009651926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.1032075,0.002432501,0.5433702,0.001033102,0.008751273,0.0008858147,0.0006040192,0.009159761,0.0566026,0.0006248491,0.006630599,0.2666978],"study_design_scores_gemma":[0.006750965,0.06748091,0.8726661,0.0001461931,0.008689982,0.002597706,0.0002278597,0.00674545,0.01698935,0.000618172,0.01699041,0.00009689258],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934741,0.002090479,0.0006462001,0.00007263178,0.0000103995,0.0001562411,0.001754505,0.00002628059,0.001769181],"genre_scores_gemma":[0.9955024,0.0004964361,0.0002955266,0.000105628,0.00002924547,0.0001107253,0.002999304,0.00000817437,0.0004526046],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001830827,"threshold_uncertainty_score":0.009682477,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02423019230298953,"score_gpt":0.3202352319545786,"score_spread":0.2960050396515891,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}